page 2: Figure S1 . HCA analysis strategy. page 3: Figure S2 . Sustained IL-1β conditions reduce DEX-driven nuclear GR protein levels without a reciprocal increase in cytoplasmic GR levels. 
. HCA analysis strategy. Cells were pretreated with either vehicle (veh) or 5ng/ml IL-1β for 16h, and then treated for 1h with either veh, 10 -8 M DEX or 5ng/ml IL-1β+10 -8 M DEX, in the absence or presence of 1µg/ml IL-1ra, as indicated in the Figure. After culture, cells were fixed, permeabilized, and stained with β-actin-and GR-specific antibodies. They were then labeled with secondary fluorescent antibodies and DAPI, mounted, and subjected to automated High Content Analyses (HCA) three-color fluorescence microscopy. β-actin and DAPI staining were used to distinguish the cytoplasmic and nuclear regions of interest (ROI), respectively, in more than 2500 cells per condition. (A) ROI segmentation criteria in GR-translocation negative (veh/veh, left) and positive (veh/DEX, right) controls. β-Actin (red) + DAPI (blue), GR (green) and phase contrast (gray) images of representative fields are shown. The outlines drawn around the nucleus and cytoplasm are examples of the automated segmentation performed by the HCA imaging system in individual cells. (B) Representative fields of GR (green) and DAPI (blue) staining in each condition: veh/veh, veh/DEX, sustained IL-1β conditions (IL-1β/IL-1β+DEX) and sustained IL-1β conditions plus IL-1ra (IL-1β+IL1-ra/IL-1β+IL1-ra+DEX). . Sustained IL-1β conditions reduce DEX-driven nuclear GR protein levels without a reciprocal increase in cytoplasmic GR levels. Cells were pretreated for 16h with vehicle or 5ng/ml IL-1β, and then treated for 2h with either vehicle (B1 and B4, veh/veh) or stimulated with either 10 -8 M DEX alone (B2 and B5, veh/DEX) or 5 ng/ml IL-1β+10 -8 M DEX (B3 and B6, IL-1β / IL-1β+DEX), as shown in the table. A) The nuclear and cytoplasmic compartments were then fractionated and their lysates studied by Western blot with anti-GR antibody (n=10). Anti-α-tubulin (α-tub) and -p53 antibodies are controls for correct cytoplasmic and nuclear compartment fractionation, respectively. B) Nuclear and cytoplasmic GR protein quantification by densitometry. Data are shown as mean±SEM fold-changes in the nuclear and cytoplasmic GR under the indicated conditions compared to cells in vehicle. ## p<0.005, differences in either nuclear or cytoplasmic GR protein levels between veh/DEX-treated (B2, B5) and veh/veh-treated cells (B1, B4). **p<0.005, difference in nuclear GR between IL-1β/IL-1β+DEX treated (B3) and veh/DEX-treated cells (B2). . IL-1β alone does not promote significant nuclear GR translocation. Cells were pretreated with either vehicle or 5ng/ml IL-1β for 16h, and then cultured for 1h in medium without stimulus, or stimulated with either 10 -8 M DEX, 5ng/ml IL-1β, or 5ng/ml IL-1β+10 -8 M DEX, as indicated in the table. The cells were processed for HCA microscopy analysis as detailed in Figure S1 . Nuclear () and cytoplasmic () GR intensity results are expressed as % Mean Fluorescence Intensity (MFI)/nuclear or cytoplasmic ROI±SD (n = 3), relative to GR content in veh/vehtreated cells. # p<0.05 veh/DEX-treated (2) and IL-1β/IL-1β-treated (4) versus veh/veh-treated cells (1). *p<0.05 IL-1β/ IL-1β+DEX-treated (3) versus veh/DEX-treated cells (2). 
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